Santen Pharmaceutical Co Ltd (OTC Pink - Current Information:SNPHY)

16.41
Delayed Data
As of Apr 19
 -0.30 / -1.80%
Today’s Change
13.20
Today|||52-Week Range
17.27
+4.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line267.9M218.0M444.6M212.9M
 
 
 
 
 
Depreciation39.1M63.1M77.8M91.3M
 
 
 
 
 
Total Other Cash Flow-40.6M5.5M-258.7M-118.0M
 
 
 
 
 
Funds From Operations266.3M286.6M263.7M186.2M
 
 
 
 
 
Funds From/For Other Operating Expenses7.8M56.3M76.1M86.1M
 
 
 
 
 
Net Cash Flow - Operating Activities258.5M230.3M187.6M100.1M
 
 
 
 
 
 
InvestingIncrease In Investments-49.3M-1.8M-18.6M-4.4M
 
 
 
 
 
Decrease In Investments30.3M39.3M22.5M12.8M
 
 
 
 
 
Capital Expenditures-47.7M-27.0M-35.8M-38.3M
 
 
 
 
 
Fixed Asset Disposal109.6K5.9M380.6M36.9K
 
 
 
 
 
Net Assets From Acquisitions 0.000.000.00-176.0M
 
 
Other Investing - Uses-69.7K-544.2K-199.9K-5.0M
 
 
 
 
 
Net Cash Flow Investing-66.7M-559.7M308.6M-260.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.00362.8M4.2M27.7M
 
 
 
 
Long Term Debt Reduction0.00-26.9M-126.1M-88.0M
 
 
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-59.8K0.000.00-114.3M
 
 
 
Common Dividends-82.1M-75.0M-82.7M-99.3M
 
 
 
 
 
Cash Dividends Paid - Total-82.1M-75.0M-82.7M-99.3M
 
 
 
 
 
Other Sources - Financing3.0M1.8M4.1M9.2M
 
 
 
 
 
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing-79.2M262.7M-200.5M-264.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash12.8M8.1M-13.6M-13.9M
 
 
 
 
 
 
Net Change In Cash112.7M-66.8M295.8M-424.9M